Immunocryosurgery for Non-superficial Basal Cell Carcinoma: A Prospective, Open-label Phase III Study for Tumours ≤ 2 cm in Diameter

Acta Dermato Venereologica ◽

10.2340/00015555-1609 ◽

2014 ◽

Vol 94 (1) ◽

pp. 38-44 ◽

Author(s):

G Gaitanis ◽

I Bassukas

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Iii ◽

Open Label Phase ◽

Phase Iii Study ◽

Superficial Basal Cell Carcinoma

Download Full-text

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

British Journal of Dermatology ◽

10.1111/j.1365-2133.2005.06486.x ◽

2005 ◽

Vol 152 (5) ◽

pp. 939-947 ◽

Author(s):

H.J. Schulze ◽

B. Cribier ◽

L. Requena ◽

J. Reifenberger ◽

C. Ferrandiz ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Iii ◽

Phase Iii Study ◽

Superficial Basal Cell Carcinoma

Download Full-text

988 An open-label phase 2 clinical trial of topical remetinostat gel for basal cell carcinoma

Journal of Investigative Dermatology ◽

10.1016/j.jid.2019.03.1064 ◽

2019 ◽

Vol 139 (5) ◽

pp. S171

Author(s):

N. Urman ◽

S. Eichstadt ◽

H. Do ◽

A.N. Mirza ◽

S. Li ◽

...

Keyword(s):

Clinical Trial ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase 2 ◽

Open Label Phase ◽

Phase 2 Clinical Trial

Download Full-text

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2007.05.022 ◽

2007 ◽

Vol 57 (4) ◽

pp. 616-621 ◽

Author(s):

Thomas K. Eigentler ◽

Anne Kamin ◽

Benjamin M. Weide ◽

Helmut Breuninger ◽

Ulrich M. Caroli ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Low Risk ◽

Phase Iii ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Faculty Opinions recommendation of Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.721063077.793505937 ◽

2015 ◽

Author(s):

John Carucci

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Iii ◽

Two Phase ◽

Superficial Basal Cell Carcinoma

Download Full-text

3LBA CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31926-8 ◽

2015 ◽

Vol 51 ◽

pp. S708 ◽

Author(s):

P. Sharma ◽

B. Escudier ◽

D.F. McDermott ◽

S. George ◽

H.J. Hammers ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Iii ◽

Advanced Renal Cell Carcinoma ◽

Open Label Phase ◽

Phase Iii Study

Download Full-text

An open‐label prospective study to assess short incubation time white LED light photodynamic therapy in the treatment of superficial basal cell carcinoma

Photodermatology Photoimmunology & Photomedicine ◽

10.1111/phpp.12750 ◽

2021 ◽

Author(s):

Rebecca Hellen ◽

Eilis Nic Dhonncha ◽

Alison Havelin ◽

Ann Kavanagh ◽

Blaithin Moriarty ◽

...

Keyword(s):

Photodynamic Therapy ◽

Basal Cell Carcinoma ◽

Prospective Study ◽

Cell Carcinoma ◽

Incubation Time ◽

White Led ◽

Superficial Basal Cell Carcinoma ◽

Short Incubation Time

Download Full-text

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.11.066 ◽

2004 ◽

Vol 50 (5) ◽

pp. 722-733 ◽

Author(s):

John Geisse ◽

Ivor Caro ◽

Jane Lindholm ◽

Loren Golitz ◽

Patti Stampone ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Iii ◽

Two Phase ◽

Superficial Basal Cell Carcinoma

Download Full-text

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Annals of Oncology ◽

10.1016/j.annonc.2020.04.001 ◽

2020 ◽

Vol 31 (7) ◽

pp. 942-950 ◽

Author(s):

R.L. Ferris ◽

R. Haddad ◽

C. Even ◽

M. Tahara ◽

M. Dvorkin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma ◽

Phase Iii ◽

Open Label Phase ◽

Phase Iii Study

Download Full-text

A randomized, double blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA and narrowband red light in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT)

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.48 ◽

2019 ◽

Vol 3 ◽

pp. S48

Author(s):

V Laquer ◽

S Bruce ◽

T Schlesinger ◽

N Zeitouni ◽

A Torres ◽

...

Keyword(s):

Photodynamic Therapy ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Red Light ◽

Phase Iii ◽

Double Blind ◽

Safety And Efficacy ◽

Multicenter Phase ◽

Phase Iii Study ◽

Superficial Basal Cell Carcinoma

Abstract not available.

Download Full-text

Randomized, open-label, phase III study comparing irinotecan plus S-1 with S-1 alone in patients with advanced esophageal squamous cell carcinoma after failure of prior platinum- or taxane-based chemotherapy: Results of an interim analysis

Annals of Oncology ◽

10.1093/annonc/mdw435.18 ◽

2016 ◽

Vol 27 ◽

pp. vi563 ◽

Author(s):

J. Huang ◽

Y. Liu ◽

S. Dai ◽

P. Lu ◽

Y. Ba ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Interim Analysis ◽

Phase Iii ◽

Open Label Phase ◽

Phase Iii Study

Download Full-text